Christopher M. Yea, PhD
Chief Development Officer

Chris holds a BSc and PhD in Biochemistry from the University of Bristol, UK. Following post-doctoral work, he spent several years at Roussel-UCLAF and Hoechst Marion Roussel before joining Ferring Pharmaceuticals. Chris led the Biology group and was responsible for transition of candidates into development. In 2008, Chris co-led the spin-out of Vantia Ltd and most recently was Chief Operating Officer where he was responsible for development activities through Phase 3 trials.

In his position as Chief Development Officer, Chris is responsible for all development-related activities within KalVista Pharmaceuticals.

Senior Management

our TEAM

 

YOU ARE NOW LEAVING KALVISTA.COM

You are now being directed to another KalVista website that contains information about specific treatment(s)

PROCEED TO SITE >>> Cancel